Pargamicin A, a novel cyclic peptide antibiotic from Amycolatopsis sp.

37Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A novel cyclic peptide antibiotic, pargamicin A was isolated from the culture broth of an actinomycete strain. The producing organism, designated ML1-hF4, was identified as a member of the genus Amycolatopsis. Pargamicin A was identified as a novel cyclic hexapeptide antibiotic containing piperazic acid by various spectroscopic analyses. Pargamicin A showed potent antibacterial activity against Staphylococcus aureus strains including MRSA and Enterococcus faecalis/faecium strains including VRE. © Japan Antibiotics Research Association.

Cite

CITATION STYLE

APA

Igarashi, M., Sawa, R., Kinoshita, N., Hashizume, H., Nakagawa, N., Homma, Y., … Akamatsu, Y. (2008). Pargamicin A, a novel cyclic peptide antibiotic from Amycolatopsis sp. Journal of Antibiotics, 61(6), 387–393. https://doi.org/10.1038/ja.2008.54

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free